Bahija Jallal
Chief Executive Officer at IMMUNOCORE HOLDINGS PLC
Net worth: 2 M $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ahmed Hamdy | M | 59 | 11 years | |
| Zheng Bin Yao | M | 58 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | 12 years |
| David Berman | M | - |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | 9 years |
| Travis Coy | M | 43 |
Immunocore Ltd.
 Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | 5 years |
| John Bell | M | 71 | 9 years | |
| Roy Herbst | M | 60 |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | 3 years |
| Kristine Peterson | F | 64 |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | 7 years |
| Peter Ratcliffe | M | 69 |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | 4 years |
| Marc Dunoyer | M | 71 | 11 years | |
| Gail Boudreaux | F | 63 | 7 years | |
| Elizabeth Tallett | F | 74 | 11 years | |
| Jim Kastenmayer | M | 52 | 9 years | |
| Stuart Lutzker | M | 63 | 3 years | |
| John Saia | M | 51 | 4 years | |
| Stephen V. Tanal | M | - | 3 years | |
| Blair Todt | M | 56 | 4 years | |
| Pascal Soriot | M | 64 | 12 years | |
| Robert Dixon | M | 68 | 13 years | |
| Robin LaChapelle | F | 51 | 6 years | |
| Barbara White | M | 73 |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.
The Johns Hopkins University
| 5 years |
| Ronald Penczek | M | 59 | 19 years | |
| Antonio Neri | M | 56 | 7 years | |
| Deborah DiSanzo | F | 64 | 7 years | |
| Winston Kung | M | 48 | - | |
| Michael Bell | M | 55 | 3 years | |
| Nazneen Rahman | M | - | 7 years | |
| Mohammed Dar | M | - |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | 11 years |
| Shu Kam Mok | M | 63 | 5 years | |
| Chris Rigg | M | - | - | |
| Meghan Joyce | F | 40 | 3 years | |
| Christian Nolet | M | 67 | 1 years | |
| Dustin Wilcox | M | - | 6 years | |
| Siddharth Kaul | M | 63 |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | 2 years |
| Beth Marek | F | - |
The Johns Hopkins University
| - |
| Jill A. Becher | F | - | - | |
| Lily Hepworth | F | - | 6 years | |
| Paula Boggs | F | 64 |
The Johns Hopkins University
| - |
| Sherilyn McCoy | F | 65 | 7 years | |
| Ryan Schneider | M | 54 | 5 years | |
| Myrtle Potter | F | 65 | 3 years | |
| James Healy | M | 59 | 1 years | |
| R. Clark | M | 71 | 10 years | |
| David Hodgson | M | 67 |
The Johns Hopkins University
| - |
| Philip Broadley | M | 63 | 7 years | |
| Ramiro Peru | M | 68 | 20 years | |
| Lewis Hay | M | 68 | 11 years | |
| Carl Gordon | M | 59 | 2 years | |
| Pam Cheng | F | 53 | 9 years | |
| Vijaya Gadde | F | 49 | 4 years | |
| Mark Kaye | M | 45 | 1 years | |
| Deanna Strable-Soethout | F | 55 | 2 years | |
| Robert Perez | M | 59 | 5 years | |
| Mike Gutch | M | 58 |
The Johns Hopkins University
| 4 years |
| Susan DeVore | F | 65 | 3 years | |
| Charles Kahn | M | 72 |
The Johns Hopkins University
| - |
| Carey Priebe | M | - |
The Johns Hopkins University
| - |
| Mike Armstrong | M | 85 |
The Johns Hopkins University
| - |
| Donald J. Shepard | M | 77 |
The Johns Hopkins University
| - |
| Shantanu Agrawal | M | 47 | 3 years | |
| Gail McGovern | F | 72 |
The Johns Hopkins University
| - |
| Paul M. Ness | M | 78 |
The Johns Hopkins University
| 45 years |
| Barclay Knapp | M | 67 |
The Johns Hopkins University
| - |
| James Anderson | M | 65 |
The Johns Hopkins University
| - |
| James G. Lazar | M | - |
The Johns Hopkins University
| - |
| James R. Calvin | M | - |
The Johns Hopkins University
| - |
| Mike Hankin | M | 66 |
The Johns Hopkins University
| - |
| N. Coles | M | 63 |
The Johns Hopkins University
| - |
| Charles I. Clarvit | M | 68 |
The Johns Hopkins University
| - |
| Edward Zyszkowski | M | - |
The Johns Hopkins University
| 15 years |
| Charles G. Drake | M | 83 |
The Johns Hopkins University
| - |
| Ethan D. Leder | M | - |
The Johns Hopkins University
| - |
| Scott Semple | M | - |
The Johns Hopkins University
| - |
| Gary F. Jonas | M | 79 |
The Johns Hopkins University
| - |
| Nael Osman | M | - |
The Johns Hopkins University
| - |
| Ankit Mahadevia | M | 43 |
The Johns Hopkins University
| - |
| Gerald M. Masson | M | - |
The Johns Hopkins University
| - |
| Kathleen L. Kiernan | M | - |
The Johns Hopkins University
| - |
| Paul A. Bottomley | M | 70 |
The Johns Hopkins University
| 30 years |
| Christina Roskovich | F | - |
The Johns Hopkins University
| - |
| Michela Gallagher | M | - |
The Johns Hopkins University
| - |
| Donna M. Neale | M | - |
The Johns Hopkins University
| - |
| David Michael Lampton | M | - |
The Johns Hopkins University
| - |
| Thomas Graham | M | - |
The Johns Hopkins University
| - |
| Fouad Ajami | M | - |
The Johns Hopkins University
| - |
| Sean P. Roddy | M | - |
The Johns Hopkins University
| - |
| H. Furlong Baldwin | M | 92 |
The Johns Hopkins University
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Wayne T. Hockmeyer | M | 79 |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | 19 years |
| Joseph Swedish | M | 72 | 5 years | |
| David Mott | M | 58 |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | 16 years |
| Howard H. Pien | M | 66 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | 3 years |
| Simon Lowth | M | 62 | 6 years | |
| Julie Brown | F | 62 | 14 years | |
| Leif Valdemar Johansson | M | 73 | 11 years | |
| Sean P. Lance | M | 77 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | 6 years |
| Gloria McCarthy | F | 71 | 18 years | |
| David Brennan | M | 70 | 13 years | |
| John Gallina | M | 64 | 15 years | |
| Reginald Seeto | M | 52 |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | 8 years |
| Ursula B. Bartels | F | 66 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | 2 years |
| James A. Nash | M | 73 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 79 | 79.00% |
| United Kingdom | 28 | 28.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Bahija Jallal
- Personal Network
